In Vitro Evaluation of High Mobility Group Box 1 Protein Removal with Various Membranes for Continuous Hemofiltration

Miho Yumoto, Osamu Nishida, Kazuhiro Moriyama, Yasuyo Shimomura, Tomoyuki Nakamura, Naohide Kuriyama, Yoshitaka Hara, Shingo Yamada

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The high mobility group box 1 protein (HMGB1) is an alarmin that plays an important role in sepsis and has been recognized as a promising target with a wide therapeutic window; however, no drugs and devices are currently in practical use. We hypothesized that hemofilters composed of porous membranes or cytokine-adsorbing membranes could remove HMGB1 from the blood. We performed experimental hemofiltration in vitro using four types of hemofilters composed of different membranes specifically designed for continuous hemofiltration. The test solution was a 1000-mL substitution fluid containing 100μg of HMGB1 and 35g of bovine serum albumin. Experimental hemofiltration was conducted for 360min in a closed loop circulation system. Among the four membranes, surface-treated polyacrylonitrile (AN69ST) showed the highest capacity to adsorb HMGB1; it adsorbed nearly 100μg of HMGB1 in the initial 60min and showed a markedly high clearance rate (60.8±5.0mL/min) at 15min. The polymethylmethacrylate membrane had half of the adsorption capacity of the AN69ST membrane. Although the highest sieving coefficient for HMGB1 was obtained with the high cut-off polyarylethersulfone membrane, which correlated with a constant filtrate clearance rate, albumin loss was observed. However, no such removal of both HMGB1 and albumin was observed with the polysulfone membrane and tubing. We conclude that continuous hemofiltration using the AN69ST membrane is a promising approach for HMGB1-related sepsis.

Original languageEnglish
Pages (from-to)385-393
Number of pages9
JournalTherapeutic Apheresis and Dialysis
Volume15
Issue number4
DOIs
Publication statusPublished - 01-08-2011

Fingerprint

HMGB1 Protein
Hemofiltration
Membranes
Albumins
Sepsis
In Vitro Techniques
Polymethyl Methacrylate
Bovine Serum Albumin
Adsorption
Cytokines
Equipment and Supplies

All Science Journal Classification (ASJC) codes

  • Hematology
  • Nephrology

Cite this

Yumoto, Miho ; Nishida, Osamu ; Moriyama, Kazuhiro ; Shimomura, Yasuyo ; Nakamura, Tomoyuki ; Kuriyama, Naohide ; Hara, Yoshitaka ; Yamada, Shingo. / In Vitro Evaluation of High Mobility Group Box 1 Protein Removal with Various Membranes for Continuous Hemofiltration. In: Therapeutic Apheresis and Dialysis. 2011 ; Vol. 15, No. 4. pp. 385-393.
@article{03b99740f1c84c8db56a22e2a4a2135d,
title = "In Vitro Evaluation of High Mobility Group Box 1 Protein Removal with Various Membranes for Continuous Hemofiltration",
abstract = "The high mobility group box 1 protein (HMGB1) is an alarmin that plays an important role in sepsis and has been recognized as a promising target with a wide therapeutic window; however, no drugs and devices are currently in practical use. We hypothesized that hemofilters composed of porous membranes or cytokine-adsorbing membranes could remove HMGB1 from the blood. We performed experimental hemofiltration in vitro using four types of hemofilters composed of different membranes specifically designed for continuous hemofiltration. The test solution was a 1000-mL substitution fluid containing 100μg of HMGB1 and 35g of bovine serum albumin. Experimental hemofiltration was conducted for 360min in a closed loop circulation system. Among the four membranes, surface-treated polyacrylonitrile (AN69ST) showed the highest capacity to adsorb HMGB1; it adsorbed nearly 100μg of HMGB1 in the initial 60min and showed a markedly high clearance rate (60.8±5.0mL/min) at 15min. The polymethylmethacrylate membrane had half of the adsorption capacity of the AN69ST membrane. Although the highest sieving coefficient for HMGB1 was obtained with the high cut-off polyarylethersulfone membrane, which correlated with a constant filtrate clearance rate, albumin loss was observed. However, no such removal of both HMGB1 and albumin was observed with the polysulfone membrane and tubing. We conclude that continuous hemofiltration using the AN69ST membrane is a promising approach for HMGB1-related sepsis.",
author = "Miho Yumoto and Osamu Nishida and Kazuhiro Moriyama and Yasuyo Shimomura and Tomoyuki Nakamura and Naohide Kuriyama and Yoshitaka Hara and Shingo Yamada",
year = "2011",
month = "8",
day = "1",
doi = "10.1111/j.1744-9987.2011.00971.x",
language = "English",
volume = "15",
pages = "385--393",
journal = "Therapeutic Apheresis and Dialysis",
issn = "1744-9979",
publisher = "Wiley-Blackwell",
number = "4",

}

In Vitro Evaluation of High Mobility Group Box 1 Protein Removal with Various Membranes for Continuous Hemofiltration. / Yumoto, Miho; Nishida, Osamu; Moriyama, Kazuhiro; Shimomura, Yasuyo; Nakamura, Tomoyuki; Kuriyama, Naohide; Hara, Yoshitaka; Yamada, Shingo.

In: Therapeutic Apheresis and Dialysis, Vol. 15, No. 4, 01.08.2011, p. 385-393.

Research output: Contribution to journalArticle

TY - JOUR

T1 - In Vitro Evaluation of High Mobility Group Box 1 Protein Removal with Various Membranes for Continuous Hemofiltration

AU - Yumoto, Miho

AU - Nishida, Osamu

AU - Moriyama, Kazuhiro

AU - Shimomura, Yasuyo

AU - Nakamura, Tomoyuki

AU - Kuriyama, Naohide

AU - Hara, Yoshitaka

AU - Yamada, Shingo

PY - 2011/8/1

Y1 - 2011/8/1

N2 - The high mobility group box 1 protein (HMGB1) is an alarmin that plays an important role in sepsis and has been recognized as a promising target with a wide therapeutic window; however, no drugs and devices are currently in practical use. We hypothesized that hemofilters composed of porous membranes or cytokine-adsorbing membranes could remove HMGB1 from the blood. We performed experimental hemofiltration in vitro using four types of hemofilters composed of different membranes specifically designed for continuous hemofiltration. The test solution was a 1000-mL substitution fluid containing 100μg of HMGB1 and 35g of bovine serum albumin. Experimental hemofiltration was conducted for 360min in a closed loop circulation system. Among the four membranes, surface-treated polyacrylonitrile (AN69ST) showed the highest capacity to adsorb HMGB1; it adsorbed nearly 100μg of HMGB1 in the initial 60min and showed a markedly high clearance rate (60.8±5.0mL/min) at 15min. The polymethylmethacrylate membrane had half of the adsorption capacity of the AN69ST membrane. Although the highest sieving coefficient for HMGB1 was obtained with the high cut-off polyarylethersulfone membrane, which correlated with a constant filtrate clearance rate, albumin loss was observed. However, no such removal of both HMGB1 and albumin was observed with the polysulfone membrane and tubing. We conclude that continuous hemofiltration using the AN69ST membrane is a promising approach for HMGB1-related sepsis.

AB - The high mobility group box 1 protein (HMGB1) is an alarmin that plays an important role in sepsis and has been recognized as a promising target with a wide therapeutic window; however, no drugs and devices are currently in practical use. We hypothesized that hemofilters composed of porous membranes or cytokine-adsorbing membranes could remove HMGB1 from the blood. We performed experimental hemofiltration in vitro using four types of hemofilters composed of different membranes specifically designed for continuous hemofiltration. The test solution was a 1000-mL substitution fluid containing 100μg of HMGB1 and 35g of bovine serum albumin. Experimental hemofiltration was conducted for 360min in a closed loop circulation system. Among the four membranes, surface-treated polyacrylonitrile (AN69ST) showed the highest capacity to adsorb HMGB1; it adsorbed nearly 100μg of HMGB1 in the initial 60min and showed a markedly high clearance rate (60.8±5.0mL/min) at 15min. The polymethylmethacrylate membrane had half of the adsorption capacity of the AN69ST membrane. Although the highest sieving coefficient for HMGB1 was obtained with the high cut-off polyarylethersulfone membrane, which correlated with a constant filtrate clearance rate, albumin loss was observed. However, no such removal of both HMGB1 and albumin was observed with the polysulfone membrane and tubing. We conclude that continuous hemofiltration using the AN69ST membrane is a promising approach for HMGB1-related sepsis.

UR - http://www.scopus.com/inward/record.url?scp=80052001687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052001687&partnerID=8YFLogxK

U2 - 10.1111/j.1744-9987.2011.00971.x

DO - 10.1111/j.1744-9987.2011.00971.x

M3 - Article

C2 - 21884474

AN - SCOPUS:80052001687

VL - 15

SP - 385

EP - 393

JO - Therapeutic Apheresis and Dialysis

JF - Therapeutic Apheresis and Dialysis

SN - 1744-9979

IS - 4

ER -